AbCellera Finds Antibody Candidates Other Technologies Might Not
Emerging Company Profile: A platform research company, AbCellera is not developing any drugs, but has seen triple-digit revenue growth each...
Scrip - March 15, 2019

Going Generic: Big Brands Poised To Lose Marketing Exclusivity In The US In 2019
With the first generic versions of blockbuster brands like Advair, Lyrica, Restasis and Sensipar and the first biosimilars of Herceptin...
Scrip - March 15, 2019

Asia Deal Watch: Athenex Changes Mind, Gets Back Chinese Rights To Actinic Keratosis Candidate
Following a positive Phase III data readout for KX2-391, Athenex requests dissolution of its recent deal conferring rights to the...
Scrip - March 15, 2019

Shorter Treatment Time For Chagas Could Blunt Kissing Bug Disease
Chagas is in the spotlight with Novartis, Bayer and DNDi running different trials designed to tackle the neglected tropical parasitic...
Scrip - March 15, 2019

Canadian Body Welcomes Pharmacare Report
An interim report on implementing national pharmacare in Canada that highlights the importance of cost savings and access to medicines...
Scrip - March 15, 2019

Oxford Biomedica, Microsoft Pact Aims At Better, Cheaper Lentiviral Vectors
Oxford Biomedica and Microsoft have joined forces to improve the yield and quality of next-generation gene therapy vectors using the...
Scrip - March 15, 2019

Cancer, Rare Disease Drugs To Be Covered As China Expands Reimbursement
China's national reimbursement drug list will undergo a much anticipated expansion in 2019, and therapies for cancer, pediatric and rare...
Scrip - March 15, 2019

Amazon Adds Masks-Specialist Fast Beauty Co. To ‘Our Brands’ Portfolio
The mega-retailer has been quietly growing its selection of private-label and Amazon-exclusive brands, recently adding Fast Beauty Co., which targets...
The Pink Sheet - March 18, 2019

Alvotech Starts European Trial For High-Concentration Adalimumab
Icelandic developer Alvotech is looking to set itself apart from the pack offering biosimilar rivals to Humira by conducting a...
The Pink Sheet - March 18, 2019

Italy Moves To Raise Biosimilar Use & Awareness
The use of biosimilars is growing in Italy, but the authorities want their market share to rise further and so...
The Pink Sheet - March 18, 2019

Australia Consults On Adopting EU Extrapolation Paper And Other Guidelines
The Australian regulator has proposed adopting several European Medicines Agency guidelines. For some of these guidelines, the Therapeutic Goods Administration...
The Pink Sheet - March 18, 2019

Execs On The Move, March 2018
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
The Pink Sheet - March 18, 2019

ImmunoGen CEO: Solving Cancer’s Access Challenge With Data, Differentiation And A Big Dose of Bipartisanship
ImmunoGen CEO Mark Enyedy, a leading proponent of targeted ADC oncologics, explains to In Vivo how high risk – and dogged resilience – are...
The Pink Sheet - March 18, 2019

Cosmetics Weekly Trademark Review: March 5-March 12
Personal-care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3...
The Pink Sheet - March 18, 2019

Pipeline Watch: Phase III Starts In PTSD, Ulcerative Colitis And Prader-Willi Syndrome
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical...
The Pink Sheet - March 18, 2019

UK Medtech Market Access: More About Mindset Than The Money
The journey from medtech concept to implementation is long and slow, and new ideas often don’t make it all the...
The Pink Sheet - March 18, 2019

Zur Rose Steams Ahead With Acquisition-Led Expansion Amid Investor Concerns
Zur Rose adds French online retail platform Doctipharma as two board members resign over “differences of opinion” with regards to...
The Pink Sheet - March 18, 2019

Zentiva Set To Acquire Romania's Solacium
Zentiva has signed its first acquisition after it was carved out from Sanofi last year to become an independent company...
The Pink Sheet - March 18, 2019

India’s Top Court Tells Singhs To Come Up With Plan To Pay Daiichi, Uphold Nation’s ‘Honor’
India’s Supreme Court has told Malvinder Singh and Shivinder Singh, once corporate billionaires, to work out a strategy within two...
The Pink Sheet - March 18, 2019

Alvogen Fails In Revlimid IPR Attempt
Alvogen’s inter partes review petition challenging a Revlimid patent in the US has been denied by the PTAB, following similar...
The Pink Sheet - March 18, 2019

QUOTED. March 18, 2019. Cisco Vicenty.
US FDA is approving 30-day change notices at a breakneck pace for device-makers enrolled in an agency program that measures...
The Pink Sheet - March 18, 2019

Deals Shaping The Medical Industry, March 2019
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of...
IN VIVO - March 13, 2019

GE Healthcare Sets Out Its Software And AI Ambitions
GE Healthcare is using its artificial intelligence platform Edison to power a new generation of medical imaging apps and devices...
IN VIVO - March 13, 2019

AUDIO: Fixing Reimbursement ‘Valley Of Death’ And Repealing The Device Tax Are Top MDMA Priorities, CEO Leahey Says
In an interview about medical device lobbying priorities, the Medical Device Manufacturers Association CEO Mark Leahey talked about efforts to...
Medtech Insight - March 15, 2019

DATA: AAOS Results Recap: Stryker’s Knee-Surgery Robot And Miach’s New ACL Scaffold
Medtech Insight's Results Recap covers major device trial results appearing on MedDeviceTracker. This is a special edition covering trial data...
Medtech Insight - March 15, 2019

DATA: Results Recap: AAOS Features Stryker’s Knee-Surgery Robot And Miach’s New ACL Scaffold
Medtech Insight's Results Recap covers major device trial results appearing on MedDeviceTracker. This is a special edition covering trial data...
Medtech Insight - March 15, 2019

Brazil Simplifies Class I Approvals To Focus On Higher-Risk Products
Brazil has passed legislation enabling class I (lowest risk) devices and diagnostics to gain market approval through a notification pathway...
Medtech Insight - March 15, 2019

QUOTED. March 15, 2019. John Russell.
Cardiva Medical believes it's in a unique position to help the growing number of patients who undergo catheter-based cardiovascular procedures...
Medtech Insight - March 15, 2019

P&G Innovates Around Water Challenges With Waterl<ss In South Africa, Liquid-Free DS3
P&G’s introduction of Waterl<ss hair-care line in South Africa, where water is a precious commodity, marks the first retail shampoo...
The Rose Sheet - March 17, 2019

Bio-Path Holdings nets $17.2mm through registered direct offering
Bio-Path Holdings Inc. (using its DNAbilize delivery platform to develop RNAi nanoparticle drugs for cancer) netted $17.2mm in a registered direct offering of 712,910 common shares at $25.95 (a 101% premium to the ten-day pre-announcement market average). A week prior to the RDO, Bio-Path announced positive interim data analysis of a Phase II trial with lead candidate prexigebersen in acute myeloid leukemia. This news caused the company's stock to jump from $4.62 per share to $38.86 in just two days. The day of the offering, trading closed at $35.13.
Strategic Transactions - March 15, 2019

Hoth Therapeutics licenses UMB's RAMBAs to develop dermatology therapeutics
Hoth Therapeutics Inc. gets exclusive rights within dermatology to develop and commercialize retinoic acid metabolism blocking agents (RAMBAs) from the University of Maryland, Baltimore (UMB) and its spin-out company Isoprene Pharmaceuticals Inc.
Strategic Transactions - March 15, 2019

Secura Bio gains worldwide license to Novartis's Farydak multiple myeloma drug
Secura Bio Inc. licensed worldwide rights to Novartis AG's multiple myeloma candidate Farydak (panobinostat).
Strategic Transactions - March 15, 2019

Edwards invests $35mm in Corvia; gets option to buy
Edwards Lifesciences Corp. invested $35mm in cardiovascular device maker Corvia Medical Inc. (formerly known as DC Devices) and gained the exclusive option to acquire the firm.
Strategic Transactions - March 15, 2019